Rayca Precision

Rayca Precision develops AI and bioinformatics platforms for precision oncology and drug discovery, using transcriptomic data and deep learning to predict drug responses and stratify cancer patients.

The company also provides automated multi-omics analysis for preclinical and clinical research workflows, and works with pharmaceutical and biotech partners to design and deliver customised drug candidate libraries, integrating computational modelling with multi-omics profiling across oncology and immunotherapy programmes.